Olympus Corp. (OCPNY) Downgraded by Zacks Investment Research
Olympus Corp. (OTCMKTS:OCPNY) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Wednesday.
According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
Shares of Olympus Corp. (OTCMKTS:OCPNY) opened at 34.68 on Wednesday. The company has a market cap of $11.87 billion, a price-to-earnings ratio of 16.12 and a beta of 1.11. Olympus Corp. has a 12 month low of $33.17 and a 12 month high of $39.49. The firm has a 50-day moving average of $34.47 and a 200 day moving average of $36.37.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/olympus-corp-ocpny-downgraded-by-zacks-investment-research/1623073.html.
Olympus Corp. Company Profile
Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.
Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.